Pacylex Pharmaceuticals CEO to Present on NMT Inhibitors as ADC Payloads at Summit
May 5, 2025 — Pacylex Pharmaceuticals CEO to present on NMT inhibitors as ADC payloads at the 2nd Annual ADC Payload Summit in Boston. Learn about the potential breakthrough in cancer treatment with zelenirstat in Phase 1 trials.